Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 20 No. 1 (2014)

Vol. 20 No. 1 (2014)

Published: 2014-01-02

Article

  • Russia-Focused Venture Capital Supports In-Bound Technology Transfer and Company Building: An Analysis of Investment Trends and Outcomes

    John M. Garvey, Shann Kerner, Axel Tillmann, Dmitry Kuzmin
    • Requires Subscription PDF (USD 25)
  • Funding biotech start-ups in a post-VC world

    William Bains, Stella Wooder, David Ricardo Munoz Guzman
    • Requires Subscription PDF (USD 25)
  • Biotechnology Venture Investing and Neurodegenerative Medicine: Promise of New Approaches to Cure an Ailing Model

    Dushon DeVere Riley, Mark Cochran
    • Requires Subscription PDF (USD 25)

Case Study

  • A biological battlefield: The potential applications of using remote sensing technology and biomarker organisms for identifying, tracking, and differentiating persons of interest within an area of operations

    Jason Rivera
    • Requires Subscription PDF (USD 25)
  • How a large biotechnology company teamed with a translation service provider to define best practices

    Jeremy Coombs
    • Requires Subscription PDF (USD 25)

From the Boardroom

  • A Social Media Manifesto

    Peter J. Pitts
    • Requires Subscription PDF (USD 25)

Legal and Regulatory Updates

  • Raw materials intended to be used for Gene, Cell and Tissue therapies: legal and regulatory considerations

    Sophie Bisson
    • Requires Subscription PDF (USD 25)
  • EU Legal & Regulatory Update

    Ewan Grist
    • Requires Subscription PDF (USD 25)

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust